Use of FAAH Inhibitors for Treating Parkinson's Disease and Restless Legs Syndrome

The present disclosure relates to methods of using fatty acid amide hydrolase (FAAH) inhibitors to treat aspects of Parkinson's disease (PD), restless legs syndrome (RLS) and periodic limb movement disorder (PLMD), the use of FAAH inhibitors for the manufacture of medicaments for use in the tre...

Full description

Saved in:
Bibliographic Details
Main Authors JOHNSTON THOMAS HENRY, PEARSON JAMES PHILIP, BROTCHIE JONATHAN MICHAEL, MILNE TODD G
Format Patent
LanguageEnglish
Published 13.06.2013
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract The present disclosure relates to methods of using fatty acid amide hydrolase (FAAH) inhibitors to treat aspects of Parkinson's disease (PD), restless legs syndrome (RLS) and periodic limb movement disorder (PLMD), the use of FAAH inhibitors for the manufacture of medicaments for use in the treatment of PD, RLS and PLMD, as well as pharmaceutically acceptable compositions comprising FAAH inhibitors for use in the treatment of PD, RLS and PLMD.
AbstractList The present disclosure relates to methods of using fatty acid amide hydrolase (FAAH) inhibitors to treat aspects of Parkinson's disease (PD), restless legs syndrome (RLS) and periodic limb movement disorder (PLMD), the use of FAAH inhibitors for the manufacture of medicaments for use in the treatment of PD, RLS and PLMD, as well as pharmaceutically acceptable compositions comprising FAAH inhibitors for use in the treatment of PD, RLS and PLMD.
Author PEARSON JAMES PHILIP
BROTCHIE JONATHAN MICHAEL
MILNE TODD G
JOHNSTON THOMAS HENRY
Author_xml – fullname: JOHNSTON THOMAS HENRY
– fullname: PEARSON JAMES PHILIP
– fullname: BROTCHIE JONATHAN MICHAEL
– fullname: MILNE TODD G
BookMark eNqNyzkOwjAQQFEXULDdYSQKKqQYA30EREGiQFnqyJBxsAgzkccNt4eCA1D95v2pGhETTlRRCwI7yNI0hzM9_M1HDgKOA1QBbfTUwdWGpydhWgkcvaD9PpZaKFBijyJwwU6gfFMb-IVzNXa2F1z8OlPL7FQd8jUO3KAM9o6EsanLTaKN3iVmu0-1-U99AGPnOWA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2013150346A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2013150346A13
IEDL.DBID EVB
IngestDate Fri Jul 19 15:35:00 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2013150346A13
Notes Application Number: US201113520644
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130613&DB=EPODOC&CC=US&NR=2013150346A1
ParticipantIDs epo_espacenet_US2013150346A1
PublicationCentury 2000
PublicationDate 20130613
PublicationDateYYYYMMDD 2013-06-13
PublicationDate_xml – month: 06
  year: 2013
  text: 20130613
  day: 13
PublicationDecade 2010
PublicationYear 2013
RelatedCompanies PEARSON JAMES PHILIP
IRONWOOD PHARMACEUTICAL, INC
BROTCHIE JONATHAN MICHAEL
MILNE TODD G
JOHNSTON THOMAS HENRY
RelatedCompanies_xml – name: BROTCHIE JONATHAN MICHAEL
– name: MILNE TODD G
– name: JOHNSTON THOMAS HENRY
– name: IRONWOOD PHARMACEUTICAL, INC
– name: PEARSON JAMES PHILIP
Score 2.9001982
Snippet The present disclosure relates to methods of using fatty acid amide hydrolase (FAAH) inhibitors to treat aspects of Parkinson's disease (PD), restless legs...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title Use of FAAH Inhibitors for Treating Parkinson's Disease and Restless Legs Syndrome
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130613&DB=EPODOC&locale=&CC=US&NR=2013150346A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOqbokYUTRPNfFoENrb5QAxsLGgUCDDDG9nHDUlMR-yM_77XMpQn3ppe0rSXXu9-vS-AO8RWbKFV18M0jHTTSFp6SPdETxyTIG5YTwjNyWiLgdUPzJdZa1aCz00ujKoT-qOKI5JExSTvuXqvV_-fWJ6KrRQP0ZKmsid_2va0Ah3Tg0zqSfO67d5o6A1dzXXbwUQbjBWNbB_DtDqElfakIS0r7ffeuzIvZbWtVPxj2B_Rejw_gRLyChy6m95rFTh4K1zeNCykT5zCOBDIspT5nU6fPfOPZbSUvXIY2Z1sqow_vmAyjVlldN0L5q29LyzkCRujdOgKwV5xIdikKFRwBrd-b-r2ddrc_I8X82CyfRLjHMo843gBzEbHNjB24thE89GyCUZh6tip0yAVVW-GVajtWulyN_kKjprrPhB6w6hBOf_6xmvSxnl0o5j4C8-7jZg
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOKbokYUtYlmPi0CG9t8WMzYWIbyFdgMb2QfHZKYQuyM_763MpQn3ppe0rSXXu9-vS-AB0rbsUa1hhymYSSrStKWQ7wncmKoCHHDRoJoLo-2GGpeoL7O2rMSfG5zYUSd0B9RHBElKkZ5z8R7vf7_xHJEbCV_ipY4tXpxfdORCnSMDzKqJ8npmN3xyBnZkm2bwVQaTgQNbR9F1SzESgc6gkIBlt47eV7KelepuCdwOMb1WHYKJcqqULG3vdeqcDQoXN44LKSPn8Ek4JSsUuJalkd67GMZLfNeOQTtTuIL448tSJ7GLDK6HjlxNt4XErKETGju0OWc9OmCk2lRqOAc7t2ub3sybm7-x4t5MN09iXIBZbZi9BKITg1dobERxypVnzUdYRRNDT01mqiiGq2wBvV9K13tJ99BxfMH_Xm_N3y7huPWpieE3FTqUM6-vukNauYsuhUM_QWUIJCC
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Use+of+FAAH+Inhibitors+for+Treating+Parkinson%27s+Disease+and+Restless+Legs+Syndrome&rft.inventor=JOHNSTON+THOMAS+HENRY&rft.inventor=PEARSON+JAMES+PHILIP&rft.inventor=BROTCHIE+JONATHAN+MICHAEL&rft.inventor=MILNE+TODD+G&rft.date=2013-06-13&rft.externalDBID=A1&rft.externalDocID=US2013150346A1